Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
56 participants
INTERVENTIONAL
2011-10-31
2014-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Ear Acupuncture for Acute Sore Throat in Patients Unable to Take Non-steroidal Anti-inflammatory Agents (NSAIDs)
NCT01301482
SinuSonic for ETD and Facial Pain: Acoustic Vibration + Oscillating Expiratory Pressure
NCT04404036
Effect of Simethicone on Eustachian Tube Dysfunction
NCT01312038
Vaccination for Middle Ear Infection
NCT00001605
Short Term Relief of Eustachian Tube Dysfunction and Serous Otitis Media Using Intranasal Steroid Sprays
NCT00279916
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
battlefield auricular acupuncture
battlefield auricular acupuncture
Standard treatment plus ear acupuncture
Standard treatment plus ear acupuncture
placebo
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Standard treatment plus ear acupuncture
Standard treatment plus ear acupuncture
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Minimum pain score of 5 points on an 11 point scale (0-10 with 10 being the worst pain)
Exclusion:
* History of significant gastrointestinal bleed
* Previous documented history of stage 2 kidney disease or worse
* Known Pregnancy
* History of gastric bypass surgery
* Known Peritonsillar abscess (PTA)
* Throat, mouth or esophageal cancer
* Chronic oral steroids use
* Absence of one or more ears
* Active cellulitis of ear
* Ear anatomy precluding identification of acupuncture landmarks
* Non-English speaking
* Use of Hearing Aids that preclude the use of ear acupuncture
* Allergy to Ibuprofen
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mike O'Callaghan Military Hospital
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
David Moss, M.D.
Role: PRINCIPAL_INVESTIGATOR
Mike O'Callaghan Federal Hospital/Nellis Air Force Base
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mike O'Callaghan Federal Hosptial
Nellis Air Force Base, Nevada, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FWH20110008H
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.